ALS drug developer Coya upsizes proposed IPO to $32M, including warrants

Dec. 05, 2022 5:35 PM ETCoya Therapeutics, Inc. (COYA)BIIB, BG, B, IONS, JUNSWBy: Val Kennedy, SA News Editor

Initial public offering hologram, night panoramic city view of Bangkok. The financial center for multinational corporations in Asia. The concept of boosting the growth by IPO process. Double exposure.

2d illustrations and photos/iStock via Getty Images

ALS drug developer Coya Therapeutics (COYA) has disclosed terms for a proposed upsized $32M initial public offering.

Coya said in a filing that it plans to offer 3M shares with warrants to

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.